<?xml version="1.0" encoding="UTF-8"?>
<results title="zoonosis">
 <result pre="SARS and MERS almost exclusively (2). Ritonavir/lopinavir, remdesivir (repurposed from" exact="Ebola" post="and FDA emergency approved), chloroquine and hydroxychloroquine (both now"/>
 <result pre="co-authors have no conflicts of interest. References References 1.GatesBResponding to" exact="Covid-19" post="- a once-in-a-century pandemic?N Engl J Med20203821677167910.1056/NEJMp200376232109012 2.Ekins S,"/>
 <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitroCell Discov202061610.1038/s41421-020-0156-032194981 7.WangMCaoRZhangLYangXLiuJXuMShiZHuZZhongWXiaoGRemdesivir and chloroquine effectively inhibit the"/>
 <result pre="of an FDA-approved compound library identifies four small-molecule inhibitors of" exact="Middle East respiratory syndrome" post="coronavirus replication in cell cultureAntimicrob Agents Chemother20145884875488410.1128/AAC.03011-1424841269 10.DyallJColemanCMHartBJVenkataramanTHolbrookMRKindrachukJJohnsonRFOlingerGGJrJahrlingPBLaidlawMJohansenLMLear-RooneyCMGlassPJHensleyLEFriemanMBRepurposing of"/>
 <result pre="Agents Chemother20145884875488410.1128/AAC.03011-1424841269 10.DyallJColemanCMHartBJVenkataramanTHolbrookMRKindrachukJJohnsonRFOlingerGGJrJahrlingPBLaidlawMJohansenLMLear-RooneyCMGlassPJHensleyLEFriemanMBRepurposing of clinically developed drugs for treatment of" exact="Middle East respiratory syndrome" post="coronavirus infectionAntimicrob Agents Chemother20145884885489310.1128/AAC.03036-1424841273 11.BakerNCEkinsSWilliamsAJTropshaAA bibliometric review of drug"/>
</results>
